CA2135295A1 - Derives de l'arabinogalactane, et leur utilisation - Google Patents
Derives de l'arabinogalactane, et leur utilisationInfo
- Publication number
- CA2135295A1 CA2135295A1 CA002135295A CA2135295A CA2135295A1 CA 2135295 A1 CA2135295 A1 CA 2135295A1 CA 002135295 A CA002135295 A CA 002135295A CA 2135295 A CA2135295 A CA 2135295A CA 2135295 A1 CA2135295 A1 CA 2135295A1
- Authority
- CA
- Canada
- Prior art keywords
- arabinogalactan
- complex
- agent
- cell receptor
- therapeutic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/605—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the macromolecule containing phosphorus in the main chain, e.g. poly-phosphazene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002135295A CA2135295A1 (fr) | 1992-06-17 | 1992-06-17 | Derives de l'arabinogalactane, et leur utilisation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002135295A CA2135295A1 (fr) | 1992-06-17 | 1992-06-17 | Derives de l'arabinogalactane, et leur utilisation |
PCT/US1992/005091 WO1993025239A1 (fr) | 1992-06-17 | 1992-06-17 | Derives d'arabinogalactane et leurs utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2135295A1 true CA2135295A1 (fr) | 1993-12-23 |
Family
ID=4154623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002135295A Abandoned CA2135295A1 (fr) | 1992-06-17 | 1992-06-17 | Derives de l'arabinogalactane, et leur utilisation |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0646018A1 (fr) |
JP (1) | JPH07507794A (fr) |
CA (1) | CA2135295A1 (fr) |
NO (1) | NO944838L (fr) |
WO (1) | WO1993025239A1 (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5554386A (en) * | 1986-07-03 | 1996-09-10 | Advanced Magnetics, Inc. | Delivery of therapeutic agents to receptors using polysaccharides |
US5490991A (en) * | 1986-07-03 | 1996-02-13 | Advanced Magnetics, Inc. | Directed delivery of radioprotectants using a receptor specific carrier |
US5728518A (en) * | 1994-01-12 | 1998-03-17 | The Immune Response Corporation | Antiviral poly-and oligonucleotides |
FR2716625B1 (fr) * | 1994-02-25 | 1996-04-26 | Gouchet Franck Arno | Préparation et utilisation de formes pharmaceutiques et cosmétiques contenant des composés d'inclusion avec les cyclodextrines de cystéamine, sels de cystéamine, ou dérivés de la cystéamine, sous forme de sel ou non. |
US5567685A (en) * | 1994-08-16 | 1996-10-22 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Water-Soluble polyene conjugate |
US5897987A (en) | 1996-03-25 | 1999-04-27 | Advanced Reproduction Technologies, Inc. | Use of arabinogalactan in cell cryopreservation media |
US6303584B1 (en) | 1996-11-20 | 2001-10-16 | The University Of Montana | Water soluble lipidated arabinogalactan |
US6011008A (en) * | 1997-01-08 | 2000-01-04 | Yissum Research Developement Company Of The Hebrew University Of Jerusalem | Conjugates of biologically active substances |
CA2280997C (fr) | 1997-03-11 | 2013-05-28 | Perry B. Hackett | Systeme transposon a base d'adn permettant d'introduire de l'acide nucleique dans l'adn d'une cellule |
US6929936B1 (en) * | 1997-07-18 | 2005-08-16 | Danisco A/S | Composition comprising an enzyme having galactose oxidase activity and use thereof |
CA2330318A1 (fr) * | 1998-04-27 | 1999-11-04 | Larex, Inc. | Derives de l'arabinogalactane et compositions les contenant |
US7160682B2 (en) | 1998-11-13 | 2007-01-09 | Regents Of The University Of Minnesota | Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell |
IL131074A0 (en) * | 1999-07-23 | 2001-03-19 | Polygene Ltd | A biodegradable polycation composition for delivery of an anionic macromolecule |
EP1286699A2 (fr) * | 2000-05-19 | 2003-03-05 | Regents Of The University Of Minnesota | Composition pour l'introduction de composes dans des cellules |
WO2003089618A2 (fr) | 2002-04-22 | 2003-10-30 | Regents Of The University Of Minnesota | Systeme de transposons, et procedes d'utilisation |
ITMI20040928A1 (it) | 2004-05-07 | 2004-08-07 | Uni Di Bologna Dipartiment O D | Procedura per la preparazione di coniugati della doxorubicina con l'albumina umana lattosaminata |
ITMI20051743A1 (it) * | 2005-09-20 | 2007-03-21 | Uni Di Bologna Dipartimento Di Patologia Spa | Uso di coniugati della doxorubicina con albumina lattosaminata |
RU2359975C2 (ru) * | 2007-04-04 | 2009-06-27 | Институт нефтехимии и катализа РАН | Способ получения модифицированных арабиногалактанов |
CN102399238B (zh) * | 2011-12-21 | 2013-06-12 | 开封明仁药业有限公司 | 氨磷汀的制备方法 |
RU2521649C1 (ru) * | 2013-03-04 | 2014-07-10 | Федеральное Государственное Бюджетное Учреждение Науки Институт Химии И Химической Технологии Сибирского Отделения Российской Академии Наук (Иххт Со Ран) | Способ получения сульфатированных производных арабиногалактана |
WO2014176389A1 (fr) * | 2013-04-24 | 2014-10-30 | Temple University - Of The Commonwealth System Of Higher Education | Forme pharmaceutique solide contenant de l'arabinogalactane |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3200766A1 (de) * | 1981-01-14 | 1982-09-16 | Toyo Jozo Kk | Praeparat mit ausgezeichneter absorptionseigenschaft |
JPH0816118B2 (ja) * | 1988-02-03 | 1996-02-21 | 呉羽化学工業株式会社 | 抗ウイルス剤 |
JPH04501218A (ja) * | 1988-08-04 | 1992-03-05 | アドヴァンスド マグネティックス インコーポレーティッド | 受容体媒介エンドサイト―シス型mri造影剤 |
-
1992
- 1992-06-17 EP EP92914217A patent/EP0646018A1/fr not_active Withdrawn
- 1992-06-17 JP JP6501422A patent/JPH07507794A/ja active Pending
- 1992-06-17 WO PCT/US1992/005091 patent/WO1993025239A1/fr not_active Application Discontinuation
- 1992-06-17 CA CA002135295A patent/CA2135295A1/fr not_active Abandoned
-
1994
- 1994-12-14 NO NO944838A patent/NO944838L/no unknown
Also Published As
Publication number | Publication date |
---|---|
EP0646018A1 (fr) | 1995-04-05 |
JPH07507794A (ja) | 1995-08-31 |
NO944838L (no) | 1995-02-17 |
WO1993025239A1 (fr) | 1993-12-23 |
NO944838D0 (no) | 1994-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5478576A (en) | Arabinogalactan derivatives and uses thereof | |
CA2135295A1 (fr) | Derives de l'arabinogalactane, et leur utilisation | |
US5554386A (en) | Delivery of therapeutic agents to receptors using polysaccharides | |
Groman et al. | Arabinogalactan for hepatic drug delivery | |
US5433955A (en) | Site specific in vivo activation of therapeutic drugs | |
Takagishi et al. | Macromolecule‐small molecule interactions; introduction of additional binding sites in polyethyleneimine by disulfide cross–linkages | |
Aplin et al. | Preparation, Properties, and Applications of Carbohydrate Conjugates of Proteins and Lipid | |
EP2173383B1 (fr) | Linker fmoc polymère hydrolysable | |
CA2506842A1 (fr) | Amplification du ciblage medie par la biotine | |
EP0377613B1 (fr) | Conjugues de dismutase de peroxyde | |
Tsukada et al. | An anti-α-fetoprotein antibody-daunorubicin conjugate with a novel poly-L-glutamic acid derivative as intermediate drug carrier | |
Molteni | [22] Dextran and inulin conjugates as drug carriers | |
FI97692B (fi) | Menetelmä terapeuttisesti käyttökelpoisen aktivaattori-kohdistusosa -konjugaatin ja esilääkkeen valmistamiseksi | |
Enriquez et al. | Conjugation of adenine arabinoside 5'-monophosphate to arabinogalactan: synthesis, characterization, and antiviral activity | |
WO1998056424A1 (fr) | Materiaux presentant une activite biologique | |
Orlando | Modification of proteins and low molecular weight substances with hydroxyethyl starch (HES) | |
CA2023339A1 (fr) | Methode de production synthetique de glycoconjugats a liaison n | |
KR950007216B1 (ko) | 오시딕단위를 산화시키고, 환원시킴에 의해 리보솜을 비활성화시키는 당단백질을 변형시키는 방법 | |
SK9785A3 (en) | Polymeric remedy and preparation method thereof | |
EP0628315A1 (fr) | Complexe de lectine et sonde et procédé de production | |
WO1997022879A1 (fr) | Molecules modifiees du type avidine utilisees comme agents de ciblage pour le foie et les cellules du systeme reticulo-endothelial | |
Orlando | Modification of proteins and low molecular weight substances with hydroxyethyl starch (HES): HESylation-a new technology for polymer conjugation to biologically active molecules | |
Diedrich et al. | Phloretin and Phlorizin Derivative Containing Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |